Form 4: Pediatrix Medical Group Director John M. Starcher Jr. Reports Acquisition of Shares
SEC Form 4 Filing
Director John M. Starcher Jr. reported acquiring shares of Pediatrix Medical Group, Inc. on May 9, 2024.
Summary
- On May 9, 2024, John M. Starcher Jr., a director of Pediatrix Medical Group, Inc., acquired 18,360 shares of common stock.
- These shares were acquired at a price of $0.
- Following the transaction, Starcher directly owns 54,637 shares of Pediatrix Medical Group, Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it is a standard disclosure of share acquisition by a company director. The acquisition itself can be seen as a slightly positive sign.
Positives
- The acquisition of shares by a director may signal confidence in the company's future prospects.
Future Outlook
The acquired shares are subject to a vesting schedule, indicating a longer-term commitment from the director.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/09/2024 | Date of transaction: Acquisition of shares. |
| 05/09/2025 | Vesting date for the restricted shares. |
| 05/13/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.